Ketamine in Neurocritical Care: New Potentials and Perspectives.
Cureus June 1, 2025 Rudin Domi, Alma Cani, Asead Abdyli et al. 3 citations
Ketamine is an intravenous hypnotic anesthetic that acts primarily by inhibiting N-methyl-D-aspartate (NMDA) receptors, leading to a range of effects, including hypnosis, analgesia, anticonvulsant activity, anti-inflammatory action, and neuroprotection. Initially, there were concerns that ketamine might elevate intracranial pressure. However, these worries have since been dispelled, leading to...